Newlink Genetics reported $75.6M in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agenus AGEN:US $ 0.52B 0.11B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Capricor Therapeutics CAPR:US $ 0.08B 0B
Celldex Therapeutics CLDX:US $ 1.26B 0.33B
Eli Lilly And LLY:US $ 308.07B 35.35B
Idera Pharmaceuticals IDRA:US $ 0.02B 0B
Intrexon XON:US $ 0.28B 0.16B
Merk MRK:US $ 230.55B 23.1B
Nektar Therapeutics NKTR:US $ 0.71B 0.3B
Newlink Genetics NLNK:US $ 0.06B 0.01B
Pfizer PFE:US $ 294.18B 1.79B
Prothena PRTA:US 1.27B 0.44B
Sarepta Therapeutics SRPT:US $ 6.56B 0.25B
Vascular Biogenics VBLT:US 0.11B 0B
YTE INCY:US $ 16.83B 0.75B